drugset / Trial / NCT00177775

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

NCT00177775 ↗

RandomizedFactorialOpen-labelPrevention

Summary

The primary objective of this study is to assess the safety of the investigational agent, MucoMilk®, a polyclonal-antibody enriched Whey Protein Concentrate 40% (WPC-40) made of milk of immunized cows. Secondary objectives will investigate the effectiveness of MucoMilk® as an aid in the prevention of relapse of C. difficile-associated diarrhea (CDAD).

Timeline

Start
2005-04
Primary completion
—
Completion
2005-08

Outcome

Outcome not reported

Stopped: “Study is completed and analysis completed”

Drugs

EvaluationDrugModalityDoseRoute
Subject MucoMilk Protein / enzyme biologic — —